DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bemiparin sodium
Bemiparin sodium
Presentación De Powerpoint
Tanibirumab (CUI C3490677) Add to Cart
Clinical Guidelines Management of Venous Thromboembolism: a Systematic Review for a Practice Guideline Jodi B
Tumor Angiogenesis
ردﺎﺻﻣﻟا BNF 61-2011 a to Z Drugs Fact-2003
Investigation of Possible Prophylactic, Renoprotective, and Cardioprotective Effects of Thromboprophylactic Drugs Against Ischemiaereperfusion Injury
Heparin-Like Drugs with Antiangiogenic Activity
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Prophylaxis for Venous Thromboembolic Disease in Pregnancy and the Early Postnatal Period (Review)
Package Leaflet: Information for the User Zibor 2,500 IU Anti-Xa/0.2 Ml Solution for Injection in Pre-Filled Syringes Bemiparin Sodium
Centre for Reviews and Dissemination
Antiangiogenic Activities of Bemiparin Sodium, Enoxaparin Sodium, Nadroparin Calcium and Tinzaparin Sodium
Effectiveness of Bemiparin Sodium for Preventing Pregnancy Loss in Patients with MTHFR C677T Mutation and Habitual Abortus
Assessment the Effect of Preoperative Bemiparin Sodium and Enoxaparin in Patients Undergoing Orthopaedic Surgery
Identification Pharmacology
Bemiparin Sodium(BAN, Rinn) Benazepril Hydrochloride
Optimal Dosing of Bemiparin As Prophylaxis Against Venous Thromboembolism in Surgery for Cancer: an Audit of Practice
Top View
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Thromboprophylaxis in Ambulatory Trauma Patients Requiring Temporary Limb Immobilisation
TABLE E-1 Clinical Studies of Thromboprophylaxis Following
Reactions 1244 - 21 Mar 2009 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Effect of Bemiparin on Neointimal Hyperplasia and Endothelial Cell Proliferation in a Rabbit Carotid Artery Model
(PDF) Download
Supplementary Data
Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among Intensive Care Unit Patients
Anticoagulation with Low-Molecular-Weight Heparin in Patients with Heart Diseases
Bemiparin Pharmaceutical Form(S)/Strength: Solution for Injection in Pre-Filled Syringes, 25,000 IU Per Ml P-RMS: ES/H/PSUR/0020/001 Date of FAR: 12.01.2011
HIBOR ® Bemiparin
Venous Thromboembolism in Patients with Heart Failure: In-Hospital and Chronic Use of Anti-Coagulants for Prevention
Evaluation of the Deep Vein Recanalisation and Function After Low Molecular Weight Heparin (Calcium Nadroparine) Therapy of Deep Vein Thrombosis